Gregory Amidon Re-Elected to USP Board

Congratulations to Gregory Amidon, PhD, Research Professor of Pharmaceutical Sciences, who was re-elected to serve on the US Pharmacopeia (USP) Board of Trustees representing pharmaceutical sciences at its Virtual Convention Governance Meeting in May.  Dr. Amidon’s appointment is from 2020 – 2025, he previously served on the Board from 2015-2020.

Prof. Amidon received his BS in medicinal chemistry and his PhD in pharmaceutical chemistry from the University of Michigan. After 28 years in the pharmaceutical industry, he returned to the College of Pharmacy in 2007 as a research professor of pharmaceutical sciences.

He has held various research positions in research and development and is recognized for his expertise in the physical, chemical, and mechanical property characterization of active pharmaceutical ingredients, excipients, and products as well as the development of scientific strategies for oral solid dosage form development and bioperformance.

Prof. Amidon has served in a variety of capacities as a USP Volunteer including service on the Council of Experts since 1990.  He is a member, Fellow, and past President of the American Association of Pharmaceutical Sciences (AAPS).  He is the recipient of the 2014 AAPS Research Achievement Award in Physical Pharmacy and Biopharmaceutics, the 2015 Champion of Quality award from USP, and is a past recipient of the Ebert Prize from the American Pharmacists Association.